Overview
Effect of Omacor on Triglycerides in HIV Infected Subjects
Status:
Terminated
Terminated
Trial end date:
2009-03-01
2009-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Omacor is likely to decrease lipid parameters in HIV infected subjects. In these subjects the lipid are decrease due to HAART treatmentPhase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Solvay Pharmaceuticals
Criteria
Inclusion Criteria:- Triglycerides between 200 and 800
- diagnosed HIV infection
- following HAART therapy
Exclusion Criteria:
- other malignant disease
- not compliant
- allergy against fish oil
- soy or olive oil